Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	29.2	26.14	9.7	0.46	16.58
Short-Term Investments	12.07	-	-	-	-
Cash & Short-Term Investments	41.27	26.14	9.7	0.46	16.58
Cash Growth	57.87%	169.48%	2032.09%	-97.26%	-
Other Current Assets	7.69	4.81	3.7	2.19	1.83
Total Current Assets	48.96	30.95	13.4	2.64	18.41
Net Property, Plant & Equipment	0.17	0.72	0.79	0.17	0.33
Total Assets	49.14	31.67	14.19	2.82	18.74
Accounts Payable	0.38	1.06	0.84	0.89	0.74
Accrued Expenses	1.52	3.56	3.23	2.24	1.21
Current Portion of Leases	0.12	0.56	0.33	0.16	0.15
Other Current Liabilities	16.92	18.94	13.13	-	-
Total Current Liabilities	18.94	24.12	17.53	3.28	2.11
Long-Term Leases	-	0.12	0.47	-	0.16
Total Long-Term Liabilities	-	0.12	0.47	-	0.16
Total Liabilities	18.94	24.24	18	3.28	2.26
Common Stock	0.02	0.01	0.04	0.02	0.02
Additional Paid-in Capital	158	108.69	60.7	33.52	32.41
Accumulated Other Comprehensive Income	-0	-	-	-	-
Retained Earnings	-127.83	-101.27	-64.54	-34	-15.94
Shareholders' Equity	30.2	7.43	-3.81	-0.47	16.48
Total Liabilities & Equity	49.14	31.67	14.19	2.82	18.74
Total Debt	0.12	0.68	0.79	0.16	0.31
Net Cash (Debt)	41.15	25.46	8.91	0.3	16.27
Net Cash Growth	61.63%	185.82%	2869.33%	-98.16%	-
Net Cash Per Share	2.59	3.80	3.63	0.20	13.94
Book Value	30.2	7.43	-3.81	-0.47	16.48
Book Value Per Share	1.90	1.11	-1.55	-0.31	14.12
Tangible Book Value	30.2	7.43	-3.81	-0.47	16.48
Tangible Book Value Per Share	1.90	1.11	-1.55	-0.31	14.12

Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q